Keeping the beat after heart surgery

Variation in the gene for the beta-1 adrenergic receptor increases the risk that a patient will have an abnormal heart rhythm after cardiac surgery.

New direction for treating lung cancer

Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer.

Powers named to American Diabetes Association board

Alvin Powers, M.D., professor of Medicine and Molecular Physiology and Biophysics, has been named to the American Diabetes Association Board of Directors.

Stanford’s Altman set for Discovery Lecture

Russ Altman, M.D., Ph.D., professor and chair of Bioengineering at Stanford University, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 6.

Is healthy obesity possible?

It might be possible to generate a “metabolically healthy” state of obesity by targeting signaling pathways that improve insulin sensitivity.

Vanderbilt Hypertension Clinic receives national comprehension designation